Kevin Michael Krause

Insider Reports History

Entity
Individual
Location
369 27 Th Street, San Francisco, CA
Signature
/s/ Lucy Day, Attorney-in-Fact for Kevin Michael Krause
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Michael Krause:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Chief Strategy Officer Common Stock 31.9K $610K $19.11 Mar 15, 2024 Direct
AN2 Therapeutics, Inc. Chief Strategy Officer Stock Option (right to buy) 60K Mar 15, 2024 Direct

Insider Reports Filed by Kevin Michael Krause

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 1 $0 4/A Mar 29, 2024 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 2 $0 4 Mar 18, 2024 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. Jan 9, 2024 5 -$115K 4 Jan 11, 2024 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. Jan 2, 2024 3 -$50.9K 4 Jan 4, 2024 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Chief Strategy Officer
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Chief Strategy Officer